General Information of the Compound
Compound ID |
CP0113847
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(+/-)-SKF-38393
Show/Hide
|
||||||||||||||||||
Synonyms |
1-Phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol
1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol
1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-
2,3,4,5-Tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
67287-49-4
BRN 1543419
C16H17NO2
CHEMBL286080
F 38393
F-38393
SK-38393
SKF 38393
SKF-38,393
SKF-38393
SKF38393
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H17NO2
|
||||||||||||||||||
Molecular Weight |
255.317
|
||||||||||||||||||
Canonical SMILES |
Oc1cc2CCNCC(c3ccccc3)c2cc1O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2
Show/Hide
|
||||||||||||||||||
InChIKey |
JUDKOGFHZYMDMF-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
67287-49-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01598, Alpha-2C adrenergic receptor
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT00957, D(2) dopamine receptor
Clinical Information about the Compound